- •Ocular Blood Flow
- •Contents
- •1: Anatomy of the Ocular Vasculatures
- •Core Messages
- •1.1 Limbus and Conjunctiva
- •1.1.1 Cornea
- •1.1.2 Vasculature Distribution in the Anterior Segment
- •1.1.3 The Conjunctiva
- •1.1.3.1 The Conjunctival Arterial Supply
- •1.1.3.2 The Conjunctival Veins
- •1.2 Uveal Tract
- •1.2.1 The Iris
- •1.2.1.1 The Major Arterial Circle of the Iris
- •1.2.2 Ciliary Body and Processes
- •1.2.3 Choroid and Suprachoroid
- •1.2.3.1 Development of the Choroidal Vasculature
- •1.2.3.2 Arteries
- •1.2.3.3 Choroidal Veins (Vortex Veins)
- •1.2.3.4 Choriocapillaris
- •1.3 Optic Nerve Vasculature
- •1.4 Retina
- •1.4.1 Development of the Retinal Vasculature
- •1.4.2 Adult Retinal Vasculature
- •1.4.3 Nonprimate Adult Retinal Vasculatures
- •1.5 Conclusions
- •References
- •Core Messages
- •2.1 Introduction
- •2.3 Stochastic Error in the Entrapment of Microspheres
- •2.4 Methodological Errors and Practical Advice
- •2.4.1 Size of the Microspheres
- •2.4.2 Physical Characteristics of Microspheres
- •2.4.4 Dissection
- •2.4.5 Detection of RM and NAM
- •2.4.6 Detection of CM and FM
- •2.5 Biological Variation
- •2.5.1 Blood Pressure
- •2.5.3 Arterial Blood Gases
- •2.5.4 Other Possible Causes for Biological Variability
- •2.6 Summary for the Clinician
- •References
- •3: Laser Doppler Flowmetry in Animals
- •Core Messages
- •3.1 Introduction
- •3.2 History
- •3.3 Theory
- •3.4 Validation
- •3.5 Calibration
- •3.6 Zero Offset
- •3.7 Effects of Oxygen
- •3.9 Measurement Depth and Sampling Volume
- •3.10 Caveats
- •References
- •4: Oxygen Measurements in Animals
- •Core Messages
- •4.1 Introduction
- •4.2.1 Oxygen Electrodes
- •4.2.2 Hypoxyprobe
- •4.2.3 Magnetic Resonance Imaging
- •4.2.4 Phosphorescence Decay
- •4.2.5 Oximetry
- •4.3.1 Vitreal Oxygen
- •4.3.2 Intraretinal Oxygen
- •4.4 Oxygen in Avascular Retinas
- •4.5 Analysis of Retinal Oxygen Utilization
- •4.5.1 Fick Principle Analyses
- •4.5.4 Other Diffusion Models
- •4.6 Physiological Variations in Retinal Oxygen
- •4.6.1 Light
- •4.6.2 Hypoxia
- •4.6.3 Hyperoxia
- •4.6.4 Hypercapnia
- •4.7 Pathophysiology and Retinal Oxygen
- •4.7.1 Vascular Occlusion
- •4.7.2 Diabetes
- •4.7.3 Retinal Detachment
- •4.7.4 Retinal Degenerative Diseases
- •4.7.5 Retinopathy of Prematurity
- •4.8 Retinal Molecular Changes Related to Oxygen
- •4.9 Oxygen in the Optic Nerve Head
- •References
- •Core Messages
- •5.1 Measuring Technique
- •5.2 Normal Values
- •5.3 Retinal Pathologies
- •5.3.1 Diabetes Mellitus
- •5.3.2 Central Retinal Vein Occlusion
- •5.4 Summary
- •References
- •Core Messages
- •6.1 Introduction
- •6.1.1 Anatomy
- •6.3 Vessel Diameter Measurements Based on Photographic and Digitally Stored Images
- •6.3.1 Basics for Measurements on Stored Images
- •6.3.1.1 Measuring Principle
- •6.3.1.4 Problems and Measuring Errors
- •6.3.1.5 Physiological Variability of Vessel Diameter
- •6.3.2 Methods
- •6.3.2.2 Microdensitometry Based on Photographic Negatives
- •6.3.2.3 Measurements Based on Digital Images
- •6.4 Diameter Assessment for Blood Flow
- •6.4.1 Assessment of Flow by Use of Doppler Technique (CLBF)
- •6.5 Retinal Vessel Analysis
- •6.5.1 Basics of Retinal Vessel Analysis
- •6.5.2 Static Vessel Analysis
- •6.5.3 Results and Limits of Static Vessel Analysis
- •6.5.4 Results and Limits of Dynamic Vessel Analysis
- •6.5.4.1 Stimulation with Flicker Light
- •6.5.4.2 Other Provocation Tests
- •6.5.5 Systems Available for Dynamic Vessel Analysis
- •6.6 Further Perspectives
- •References
- •Core Messages
- •7.1 Introduction
- •7.2 Retinal Laser Doppler Velocimetry
- •7.2.1 The Doppler Effect
- •7.2.2 Electric Field Scattered by Singly Scattering Particles Moving in a Capillary Tube
- •7.2.5 Experimental Test of the Bidirectional LDV Technique
- •7.2.7 The DSPS for RBCs Moving in a Retinal Vessel
- •7.2.7.1 Multiple Scattering of Blood
- •7.2.7.2 DSPS from RBCs Flowing in a Glass Capillary Tube
- •7.2.7.3 DSPS from Human Retinal Vessels
- •7.2.7.4 Exploring the Scattering Process
- •7.2.9 Instrumentation
- •7.2.10 Blood Flow in Retinal Vessels
- •7.2.12 Limitations, Safety, and Future Directions of the LDV Technique
- •7.2.13 Physiologic and Clinical Applications (Brief Overview)
- •7.3.1 The DSPS for RBCs Moving in the Microvascular Bed of a Tissue
- •7.3.2 Hemodynamic Parameters Derived from the DSPS
- •7.3.3 Detection Scheme for Optic Nerve and Subfoveal Choroidal Blood Flow
- •7.3.4 Critical Questions Regarding the Application of LDF to Ocular Blood Flow
- •7.3.4.1 LDF Sample Volume
- •7.3.4.2 Linearity of LDF
- •7.3.4.3 Scattering Scheme
- •7.3.5 Reproducibility of LDF
- •7.3.6 Applications of LDF
- •7.4 Summary for the Clinician
- •References
- •8: Color Doppler Imaging
- •Core Messages
- •8.1 Principles
- •8.2 Instrumentation
- •8.3 Procedure
- •8.4 Outcome Variables
- •8.5 Reproducibility
- •8.6 Physiological and Pharmacological Stimuli
- •8.7 Results in Patients with Disease
- •8.8 Advantages and Limitations
- •References
- •9: Other Approaches
- •Core Messages
- •9.1 Blue Field Entoptic Technique
- •9.1.1 Laser Speckle Technique
- •9.1.2 Pulsatile Ocular Blood Flow
- •9.1.2.1 Laser Interferometry
- •References
- •10: Systemic Determinants
- •Core Messages
- •10.1 Introduction
- •10.1.1 Ocular and Systemic Blood Flow
- •10.2 Local Skin Cooling Effect
- •10.2.1 Choroidal Blood Flow
- •10.2.2 Retinal Blood Flow
- •10.3 Aerobic Exercise
- •10.3.1 Choroidal Blood Flow
- •10.3.2 Macular Blood Flow
- •10.3.3 Retinal Blood Flow
- •10.4 Neural Activation
- •10.4.1 Valsalva Maneuver
- •10.4.2 Nicotine
- •10.5 Blood Pressure Versus Ocular Perfusion Pressure
- •10.5.1 Increased Ocular Perfusion Pressure
- •10.5.1.1 Choroidal Blood Flow
- •10.5.2 Decreased Ocular Perfusion Pressure
- •10.5.2.1 Choroidal Blood Flow
- •10.5.2.2 Optic Nerve Head Blood Flow
- •10.5.3 Neural Retinal Function
- •10.6 Blood Gases
- •10.6.1 Hyperoxia and Blood Flow
- •10.6.3 Hypoxia and Pulsatile Choroidal Blood Flow
- •10.6.4 Hyperoxia, Hypercapnia, and Retinal Function
- •10.6.5 Hypoxia, Hyperoxia, and Retinal Function
- •10.7 Regional Choroidal Perfusion
- •10.7.1 Cones Versus Rods: Structure and Function
- •10.7.2 Choroidal Angioarchitecture
- •10.7.3 Dark Adaptation
- •10.7.4 Protracted Blue Flicker
- •10.8 Aging
- •10.8.1 Structure
- •10.8.2 Blood Flow
- •10.8.3 Retinal Function
- •References
- •11: Local Determinants
- •Core Messages
- •11.1 Introduction
- •11.2 Ocular Perfusion Pressure, IOP, and the Ocular Starling Resistor Effect
- •11.3 Types of Local Control
- •11.3.1 Myogenic Local Control
- •11.3.2 Metabolic Local Control
- •11.3.3 Flow-Mediated Vasodilation
- •11.3.4 Flow Control by Intercellular Conduction
- •11.4 Ocular Local Control
- •11.4.1 Optic Nerve Head (ONH)
- •11.4.2 Choroid
- •11.4.3 Retina
- •11.4.4 Ciliary Body
- •11.4.5 Iris
- •11.5 Caveats
- •11.6 Summary for the Clinician
- •References
- •12: Neural Control of Ocular Blood Flow
- •Core Messages
- •12.1 Overview of Ocular Blood Supplies and Their Neural Control
- •12.2 Neural Control of Optic Nerve and Retinal Blood Flow
- •12.3 Neural Control of Iridial and Ciliary Body Blood Flow
- •12.4 Neural Control of Blood Flow in Orbital Glands
- •12.5 Neural Control of Choroidal Blood Flow
- •12.5.1 Importance of the Choroid
- •12.5.2 Choroidal Innervation: Overview of Anatomy
- •12.5.3 Facial Nucleus Parasympathetic Input
- •12.5.3.4 Choroidal Autoregulation and the PPG Input to Choroid – Mammals
- •12.5.3.8 Choroidal Autoregulation and the PPG Input to Choroid – Birds
- •12.5.4 Oculomotor Nucleus Parasympathetic Input
- •12.5.4.1 Ciliary Ganglion Circuitry – Mammals
- •12.5.4.2 Function of the EW-Ciliary Ganglion Circuit – Mammals
- •12.5.4.3 Ciliary Ganglion Circuitry – Birds
- •12.5.4.4 Function of vSCN-EWM-Ciliary Ganglion Circuit – Birds
- •12.5.5 Sympathetic Superior Cervical Ganglion Input
- •12.5.6 Trigeminal Sensory Input
- •12.5.7 Intrinsic Choroidal Neurons
- •12.5.8 Disturbed Neural Control of Choroidal Blood Flow in Aging and Retinal Disease
- •12.5.8.1 Effect of Aging on Retina and Choroid
- •12.5.8.2 Effect of Disease on Retina and Choroid
- •References
- •13: Endothelial and Adrenergic Control
- •Core Messages
- •13.1 Nitric Oxide
- •13.2 Endothelins
- •13.3 Arachidonic Acid Metabolites
- •13.4 Adrenergic Control
- •13.5 Alpha Receptors
- •13.6 Topical Administration
- •13.6.1 Clonidine
- •13.6.2 Brimonidine
- •13.6.3 Beta Receptors
- •13.6.4 Timolol
- •13.6.5 Human Studies
- •13.6.6 Betaxolol
- •13.6.7 Human Studies
- •13.6.8 Levobunolol
- •13.6.9 Carteolol
- •13.6.10 Serotonin
- •13.7 Carbonic Anhydrase Inhibitors
- •13.8 Acetazolamide
- •13.9 Dorzolamide
- •13.10 Retrobulbar Blood Flow
- •13.11 Retinal Blood Flow
- •13.12 Choroidal and Optic Nerve Head Blood Flow
- •13.13 Brinzolamide
- •References
- •Core Messages
- •14.1 Introduction
- •14.2 Retinal Ischemia Basic Mechanisms
- •14.3 Oxidative Stress
- •14.6 Animal Studies Relating Ischemia, Glaucoma, and Neuroprotection
- •14.6.1 Retinal Ischemia
- •14.6.6 Role of Mitochondria (Fig. 14.6)
- •References
- •Core Messages
- •15.1 Introduction
- •15.2 Retinal Blood Flow in Diabetes
- •15.3 Retinal Hypoperfusion
- •15.3.1 Mechanisms of Hypoperfusion
- •15.3.1.1 Glycaemic Control
- •15.3.1.2 Protein Kinase C
- •15.3.1.3 Ion Channel Dysfunction
- •15.4 Retinal Hyperperfusion
- •15.4.1 Mechanisms of Hyperperfusion: A Link to Hypoperfusion, Tissue Hypoxia and Retinal Leukostasis?
- •15.4.2 Retinal Autoregulation in Diabetes
- •15.5.1 Basement Membrane Thickening
- •15.5.3 Microaneurysms
- •15.5.4 Capillary Acellularity
- •15.6 Retinal Blood Flow and Vision Loss in Diabetic Retinopathy
- •15.6.1 Diabetic Macular Oedema
- •15.6.2 Proliferative Diabetic Retinopathy
- •15.7 Conclusions
- •15.8 Summary for the Clinician
- •References
- •Core Messages
- •16.1 Introduction
- •16.2 Choroidal Blood Flow
- •16.3 Systemic Vascular Factors and AMD
- •16.5 Choroidal Hemodynamic Changes in AMD
- •16.5.1 Choroidal Histopathological Vascular Changes in AMD
- •16.5.1.1 Choriocapillaris and Bruch’s Membrane in Aging and AMD
- •16.5.2 Choroidal Microcirculation in AMD
- •16.5.2.2 Choroidal Watershed Zones and Neovascularization
- •16.5.2.3 Laser Doppler Flowmetry Evaluation
- •References
- •Core Messages
- •17.1 Introduction
- •17.2 Potential Mechanisms of Ischaemic Damage in Glaucoma
- •17.2.2 Autoregulatory Disturbances
- •17.2.3 Mechanical Compression or Collapse of Vessels
- •17.2.4 Atherosclerosis
- •17.2.5 Vascular Endothelial Factors
- •17.2.6 Barriers to Nutrient Delivery
- •17.2.7 Circulating Vasoconstrictors
- •17.3 Evidence Base Supporting the Importance of Ischaemia in Glaucoma
- •17.3.1 Association and Causality
- •17.3.1.1 Reduction in Optic Nerve Head Blood Flow
- •17.3.1.2 Blood Pressure, Intraocular Pressure and Perfusion Pressure
- •17.3.1.3 Nocturnal Hypotension
- •17.3.1.4 Vasospasm
- •17.3.1.5 Endothelin and Other Circulating Peptides
- •17.3.2 Effects of Treatment
- •17.3.2.1 Calcium Channel Blockers
- •17.3.2.2 Topical Adrenergic Antagonists
- •17.3.2.4 Prostaglandin Analogues
- •17.4 Experimental Models of Ischaemia Relating to Glaucoma
- •17.4.1 Acute Ischaemia
- •17.4.2 Chronic Ischaemia
- •17.5 Summary
- •17.5.1 Diversity of Evidence
- •17.5.2 Evidence Base Compared to Intraocular Pressure
- •17.5.3 Requirements to Strengthen Evidence Base
- •References
- •Core Messages
- •18.1 Retinal Diseases
- •18.2 Uveitis
- •18.3 Optic Nerve Disorders
- •18.4 Systemic Diseases
- •References
- •Core Messages
- •19.1 Atherosclerosis
- •19.1.1 Pathogenesis of Atherosclerosis
- •19.1.2 Internal Carotid Artery Disease (ICA)
- •19.1.3 Effects on the Ocular Circulation
- •19.1.3.1 Retinal Artery Occlusion
- •Clinical Characteristics
- •Diagnosis
- •Mortality/Morbidity
- •19.1.3.2 Retinal Vein Occlusion (RVO)
- •Clinical Characteristics
- •Pathogenesis
- •Diagnosis
- •19.1.3.3 Ischemic Optic Neuropathy
- •Clinical Characteristics
- •Mortality/Morbidity
- •19.1.3.4 Asymptomatic Retinal Emboli
- •Background
- •Pathophysiology
- •19.2 Vasculitis
- •19.2.1 Takayasu’s Arteritis (Aortic Arch Syndrome)
- •19.2.1.1 Pathophysiology
- •19.2.1.2 Clinical Characteristics
- •19.2.1.3 Epidemiology
- •19.2.2 Behcet’s Disease
- •19.2.2.1 Clinical Characteristics
- •19.2.2.2 Pathogenesis
- •19.2.2.3 Diagnosis
- •19.2.2.4 Epidemiology
- •19.2.3 Thromboangiitis Obliterans
- •19.2.3.1 Diagnosis and Clinical Characteristics
- •19.2.3.2 Treatment
- •19.2.4 Temporal Arteritis
- •19.2.4.1 Epidemiology
- •19.2.4.2 Pathogenesis
- •19.2.4.3 Ocular Manifestations
- •19.2.5 Wegener’s Granulomatosis
- •19.2.5.1 Pathogenesis
- •19.2.5.2 Ocular Manifestation
- •19.2.5.3 Diagnosis
- •19.2.6 Kawasaki Disease
- •19.2.6.1 Clinical Characteristics
- •19.2.6.2 Diagnosis
- •19.3 Vascular Malformations
- •19.3.1.1 Diagnosis
- •19.3.1.2 Pathophysiology
- •19.4 Systemic Hypertension and Treatment
- •19.4.1 Etiology
- •19.4.1.1 Primary Hypertension
- •19.4.1.2 Secondary Hypertension
- •19.4.2 Pathophysiology
- •19.4.3 Pathology and Complications
- •19.4.4 Symptoms and Signs
- •19.4.5 Diagnosis of Hypertension
- •19.4.5.1 History
- •19.4.5.2 Physical Examination
- •19.4.5.3 Testing
- •19.4.6 Prognosis
- •19.4.7 General Treatment
- •19.4.7.2 Drugs
- •19.5 Hypertensive Retinopathy
- •19.5.2 Pathophysiology
- •19.5.3 Blood Pressure
- •19.5.3.1 The Risk of Stroke
- •19.5.3.2 The Risk of Coronary Heart Disease
- •19.5.4 Treatment
- •19.5.4.1 ACE Inhibitors and the Eye
- •References
- •Index
10 Systemic Determinants |
205 |
|
|
Overall, the blood flow findings combined with the blue fERGs provided compelling evidence that ChBF must have been shifted away from the subfovea, likely toward retinal regions with the highest metabolic activity, in this case toward eccentric rods because the stimulus wavelength was selected to match the spectral sensitivity of rhodopsin that is found exclusively in rods. Confirmation that blood moves from the subfoveal choroid to the peripheral choroid during a similar series of blue flashes would require simultaneous ChBF measurements in the periphery and the subfovea, which is technically very challenging. The decrease in subfoveal ChBF during the blue flash stimuli that increased activity in rod photoreceptors parallels the progressive reduction in subfoveal ChBF measured during physiological dark adaptation of the retina where the site of increasing metabolic activity was increasingly far from the fovea, in the rod-domi- nated zone of the far macula.
10.8Aging
10.8.1 Structure
Normal aging is accompanied by a reduction in the number of arterioles and venules and an associated neural loss such as a dropout in retinal ganglion cells [85]. Along with this reduction in retinal vessels, there is a modification in the geometry of arterial bifurcations that likely alters blood flow and leads to blood rarefaction of the microvasculature [86]. In addition to these changes in retinal vessels, the density and caliber of the vessels forming the choriocapillaris in the human macula also decrease, thereby causing a thinning of the choroid [87]. There is also a significant reduction in the sympathetic innervation to the choroid [88] and a loss of endothelial cells in the choriocapillaris [89]. With normal aging, a thickening of Bruch’s membrane is known to occur [87, 89] and is subject to accumulation of cholesterol, particularly in the macular region [90], thereby impairing normal diffusion of blood between the RPE and the choroid [91, 92]. All of these histological findings are compatible with an alteration in ocular hemodynamics in senescence.
10.8.2 Blood Flow
Recent technological advances such as the RVA have led to noninvasive measurements of realtime changes in retinal vessel diameter during flicker. Using this technology, Polak et al. [93] recently reported that retinal vessels dilate in response to flicker between 1 and 60 Hz. Shortly afterward, Nagel and Vilser [94] reported on a clinically usable procedure for quantifying the degree of vasodilation in retinal arteries and veins during a 12.5-Hz flicker. These latter studies formed the basis of a study that compared the timing and amplitude of change in retinal vessel caliber in healthy volunteers 20–80 years of age. In order to compare the degree of dilation between arteries and veins within and across subjects in different age groups, the data sorted by decade of life were normalized such that the prestimulus vessel diameter was designated as 100%, and subsequent changes in caliber were expressed as a percentage of that value.
The group-averaged maximal dilation for an artery and vein in response to 60 s of flicker presented at 12.5 Hz was ~6% and ~8%, respectively. This difference in the degree of vasodilation between arteries and veins was maintained across all age groups from 20 to 80 years of age. However, the overall dilation measured in arteries and veins was less for the subjects in the 60and 70-year age groups. A sample comparison of the vasodilation/vasoconstriction response profiles to flicker for a young and an elderly subject are presented in Fig. 10.20. The outstanding difference in these response profiles was the delayed and slower vasoconstriction of both artery and vein during the recovery phase for the elderly subject. Consequently, neither vessel returned to baseline within the 60-s recovery phase.
The vasodilation to flicker has been interpreted as a response to increased metabolic demand of the retina and hence a need for increased blood flow for more oxygen and metabolites needed to sustain neural activity. The failure of retinal arterioles to dilate as much as the younger subjects may be attributed to a reduction in the amount of circulating substances such as NO with age or a dropout of muscle fibers, thereby affecting the reactivity of the
206 J.V. Lovasik and H. Kergoat
YOUNG SUBJECT |
ELDERLY SUBJECT |
|
|
112 |
|
FLICKER |
|
|
RECOVERY |
b |
|
FLICKER |
|
|
RECOVERY |
|
||||
|
|
a |
|
|
|
|
|
|
|||||||||
|
110 |
|
|
|
Venous dilation |
|
|
|
|
|
Smaller venous |
|
|
||||
diameter |
|
|
|
|
|
|
|
|
|
|
|
||||||
108 |
Vein |
|
|
> arterial dilation |
|
|
Vein |
|
|
dilation in elderly |
|
|
|||||
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
106 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Slow constriction |
||
vessel |
|
|
|
|
|
|
|
|
|
|
|
|
|
of vein and artery |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
104 |
|
ARTERY |
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
retinal |
102 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
ARTERY |
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
100 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Percent |
|
|
|
|
|
|
|
baseline |
|
|
|
|
|
|
|
||
baseline |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
98 |
Rapid initial phase |
|
|
|
|
|
Speed of initial dilation |
Artery does not |
|
||||||||
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
||||||||||
|
96 |
|
of dilation |
|
|
Typical ARTERIAL |
|
|
similar to young |
|
overshoot baseline |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
in recovery |
|
||||
|
94 |
|
|
|
|
overshoot of baseline |
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0 |
20 |
40 |
60 |
80 |
100 |
120 |
140 |
160 0 |
20 |
40 |
60 |
80 |
100 |
120 |
140 |
160 |
|
|
|
|
|
|
|
|
Time (sec) |
|
|
|
|
|
|
|
|
|
Fig. 10.20 Representative retinal vessel dilation and recovery profiles in response to a 12.5-Hz flicker in young (Frame a) vs. elderly subjects (Frame b). Results from an ongoing study have revealed that retinal veins dilate biphasically as do arteries during flicker, but veins dilate to a greater degree than arteries in both young and elderly subjects. Furthermore, both arteries and veins tend to
dilate more in younger subjects than in the elderly. Interestingly, retinal arteries in younger subjects overshoot baseline diameter during the vasoconstriction recorded in the recovery phase, but arteries in elderly subjects do not show such an overshoot in recovery. In fact, neither arteries nor veins in elderly subjects regain baseline vessel diameter in the recovery interval
vessels and its ability to vasodilate. Alternatively, because there is an attrition of photoreceptors with age, it is possible that the neural retinal response to standardized flicker luminance was less in subjects over 60 years of age compared to younger subjects, thereby requiring a smaller increase in blood flow. Further studies are needed to determine the precise cause of these new findings on retinal hemodynamics in senescence. Whatever the reason for reduced arterial dilation, this vasomotor deficit may be projected to blood flow in the brain and may also indicate subtle subclinical cardiovascular deficits in senescence.
At the structural level, retinal vessel diameters were also measured in the same group of subjects in an effort to determine structural changes with age and to determine the correlation between retinal hemodynamics and structure. The retinal vessel diameter was quantified over a ~2,700-mm length to provide a more precise measure of age-related changes in vessel caliber because previous studies of vessel size were based on very narrow cross-sectional values. For the data presented in Fig. 10.21, highresolution digital fundus images were first taken with the Imedos Visualis system and then vessel diameters were quantified with their VesselMap
100 |
|
|
|
|
|
|
|
|
|
|
n = 91 |
|
|
|
C |
|
|
||
( m) |
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
95 |
|
|
|
|
|
|
|
|
|
diameter |
90 |
|
|
VEIN |
|
|
~2700 |
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
m |
|
B |
vessel |
|
|
|
|
|
|
A |
|
|
|
|
|
|
|
|
|
|
||
85 |
|
|
|
|
|
|
|
|
|
Retinal |
|
|
|
|
|
|
|
|
|
80 |
|
|
ARTERY |
|
|
|
|
||
|
|
|
|
|
|
|
|||
|
75 |
|
|
|
|
|
|
|
|
|
70 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
1 |
2 |
3 |
4 |
5 |
6 |
7 |
||
|
|
|
|
|
Decade of life |
|
|
||
Fig. 10.21 A: optic nerve head, B: white rectangle identifies the location where the first measurement of the vessel caliber was made in the course of determining the taper of the target vessel over a 2700 µm distance from the optic nerve head toward the retinal periphery. C: white line through the retinal vessel identifies the most peripheral site where the measurement of vessel caliber was made. The two solid white arrows highlight the 2700 µm length of vessel along which changes in vessel caliber were determined
software. The group-averaged vessel diameter for paired arteries and veins for each age group in this study are presented in Fig. 10.21. Overall, there is a trend for a reduction in diameter in
10 Systemic Determinants |
207 |
|
|
both arteries and veins for subjects between 20 and 80 years of age. This narrowing of retinal vessels may be an adaptation for the concomitant increase in the systemic BP and hence an increase in the OPP, although still within normal range. Inasmuch as all subjects were free of systemic and ocular diseases, it was presumed that the decrease in vessel diameter was a response to increased OPP [95].
and abnormalities in the systemic vasculature that directly affect ocular blood flow. The work described above represents some of the first initiatives to define changes in vascular perfusion at different levels within the retina and their effect on neural function in the aging eye. Additional studies are required for a complete description of changes in neurovascular coupling as a function of age.
10.8.3 Retinal Function
The normal aging process is accompanied by physiological decline in many organs, thereby decreasing the functional reserves and increasing their susceptibility to disease. However, the boundary between the functional decline linked with aging and the development of pathology is not well described in a variety of ocular diseases.
Recent studies have concluded that aging per se is associated with a variety of significant nonpathological changes in neural structure and function in the eye of healthy subjects. Specifically, the function of all major retinal neurons, including rod and cone photoreceptors, bipolar/ Mueller cells, amacrine cells [96], ganglion cells [97], the retinal nerve fiber layer [98], and the retinal ganglion cell axons within the ONH [99], is compromised in senescence. These findings allow a distinction between the effects of normal aging and the onset of ocular pathology that occurs more frequently in the elderly.
While these findings have defined the anatomical and physiological changes in the aging eye, changes in the ocular blood flow associated with aging per se are yet to be quantified. This identifies an area of fundamental and clinical research that is essential for correctly diagnosing subclinical ocular pathology related to vascular dysfunction or impaired blood flow that occurs more frequently in the aging population. ARMD is a prime example of a prominent ocular disease thought to have a vascular origin. However, a correct diagnosis of the onset of any vascular disease of the eye must rule out any effects of normal aging on retinal or choroidal perfusion
Abbreviations
ARMD |
Age-related macular degeneration |
BFE |
Blue Field Entoptoscope |
BP |
Blood pressure |
BPdiast |
Diastolic blood pressure |
BPmean |
Mean systemic blood pressure |
BPsyst |
Systolic blood pressure |
ChBF |
Choroidal blood flow |
CO2 |
Carbon dioxide |
CP |
Chromatic pulse |
CPT |
Cold pressor test |
CRA |
Central retinal artery |
CRV |
Central retinal vein |
D |
Diameter |
FAZ |
Foveal avascular zone |
fERG |
Flash electroretinogram |
FPA |
Fundus pulsation amplitude |
HR |
Heart rate |
IOP |
Intraocular pressure |
ISCEV |
International Society for |
|
Clinical Electrophysiology of Vision |
LDF |
Laser Doppler flowmetry |
NIR |
Near infrared |
NO |
Nitric oxide |
O2 |
Oxygen |
ONH |
Optic nerve head |
OPP |
Ocular perfusion pressure |
OPs |
Oscillatory potentials |
pERG |
Pattern reversal electroretinogram |
PO2 |
Partial pressure for oxygen |
POBF |
Pulsatile ocular blood flow |
Q |
Blood flow |
RPE |
Retinal pigment epithelium |
RVA |
Retinal Vessel Analyzer |
SaO2 |
Saturation of oxygen |
V |
Velocity |
VM |
Valsalva maneuver |
